News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



UPDATE 5-U.S. FDA advisers recommend COVID-19 boosters for older adults after rejecting broad approval

(Recasts with new vote) By Manojna Maddipatla and Michael Erman (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine

Monitoring PA pressure likely curbs heart-failure hospitalization in obese

By Marilynn Larkin NEW YORK (Reuters Health) - Pulmonary artery (PA) pressure monitoring reduced hospitalizations of obese patients with heart failure, regardless of ejection fraction (EF), in a

Enfortumab vedotin may trigger rare, severe skin reactions

By Marilynn Larkin NEW YORK (Reuters Health) - Post-marketing surveillance of the urothelial cancer drug enfortumab vedotin (EV) uncovered cases of Stevens-Johnson Syndrome (SJS) and toxic epidermal

Genetic testing in early AF may reveal more serious congenital problems

By Marilynn Larkin NEW YORK (Reuters Health) - Genetic testing in patients with early-onset atrial fibrillation (AF) identified a more serious disease-associated variant in 10% of cases, researchers

Circadian system implicated in asthma worsening at night

By Marilynn Larkin NEW YORK (Reuters Health) - The circadian system plays an important role in nocturnal worsening of asthma, independent of sleep and other daily behavioral or environmental cycles,

EXPLAINER-The case for, and against, COVID-19 vaccine boosters

By Reuters Staff NEW YORK (Reuters) - The U.S. government aims to begin offering COVID-19 vaccine booster shots widely next week to Americans age 16 and up. A panel of outside advisers to the Food and

U.S. FDA vaccine advisers vote in favor of COVID-19 booster shot for those 65 and older

By Reuters Staff (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older and

Biden adds measles to list of diseases that could require quarantine

By Reuters Staff WASHINGTON (Reuters) - President Joe Biden on Friday signed an executive order adding measles to a list of communicable diseases that could require quarantine after several Afghan

UPDATE 4-U.S. FDA vaccine advisers vote against COVID-19 booster shot approval

(Adds details of potential follow-up vote) By Manojna Maddipatla and Michael Erman (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted against approving COVID

UPDATE 3-U.S. FDA vaccine advisers vote against COVID-19 booster shot approval

(Recasts with panel vote) By Manojna Maddipatla and Michael Erman (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted against approving COVID-19 booster shots

Clinicians see barriers to colonoscopy completion after abnormal fecal test

By Lisa Rapaport (Reuters Health) - Many patients who receive abnormal fecal immunochemical test results may face a variety of barriers to colonoscopy completion, including cognitive and social

When U.S. ICUs are full, most states ration care by age

By Ronnie Cohen (Reuters Health) - As COVID-19 strains and tests the limits of hospitals and healthcare workers, how do we decide who to treat and who to turn away? Most U.S. states have adopted

Multimodal intervention reduces peripheral intravenous catheter failure

By Lisa Rapaport (Reuters Health) - A multimodal intervention focused on areas such as provider and patient education and hand hygiene can help reduce peripheral intravenous catheter (PIVC) failure in

White House says U.S. can roll out COVID boosters next week

By Ahmed Aboulenein and Steve Holland WASHINGTON (Reuters) - The United States is ready to roll out COVID-19 vaccine booster shots next week but only if health regulators approve the plan, White House

UPDATE 2-U.S. FDA vaccine advisory committee debates boosters for ages 16 and up

(Adds FDA official, expert comments,) By Manojna Maddipatla and Michael Erman (Reuters) - Debate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine as planned

UPDATE 1-U.S. FDA vaccine advisory committee debates boosters for ages 16 and up

(Adds details from meeting) By Manojna Maddipatla and Michael Erman (Reuters) - The debate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine moves to a panel

WHO's Tedros seen running unopposed for top job despite Ethiopia snub - sources

By Emma Farge, Francesco Guarascio and Giulia Paravicini GENEVA (Reuters) - The World Health Organization's chief looks set to run unopposed for a second term at the helm as tries to guide the world

Trial over COVID-19 outbreak in Austria's 'Ibiza of the Alps' begins

By Leonhard Foeger VIENNA (Reuters) - A Vienna court on Friday heard the first of more than a dozen lawsuits being brought against Austria over an outbreak of the coronavirus at the ski resort of

Supply fears lead EU vaccine industry to seek home comforts

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - European companies playing key supporting roles in COVID-19 vaccine manufacturing are working to move production and supply chains closer to

South Korea approves Celltrion's COVID-19 treatment for use

By Reuters Staff SEOUL (Reuters) - South Korea on Friday approved drugmaker Celltrion Inc's antibody COVID-19 treatment for infected adults in high-risk groups or those with severe symptoms. Phase III

FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration said on Thursday it has revised its emergency use authorization for Eli Lilly's COVID-19 antibody cocktail to include for use in

Use of 5-alpha-reductase inhibitors tied to lower risk of COVID-19

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Drugs commonly used to treat lower urinary-tract symptoms in men with enlarged prostate may also help protect them from COVID-19 infection,

Support for ECT in severely depressed older adults

By Megan Brooks NEW YORK (Reuters Health) - Electroconvulsive therapy (ECT) is associated with lower risk of death over one year, as well as short-lived protective effects on suicide risk, in older

Sinopharm's COVID booster reverses antibody decline, enhances cell-based responses - study

By Reuters Staff BEIJING (Reuters) - A third shot of Sinopharm's COVID-19 vaccine leads to a rebound in antibody levels that drop months after a second dose, a small-scale Chinese study showed. It

Brazil official wants halt to teen COVID-19 shots after death; health agency says no evidence for move

By Lisandra Paraguassu BRASILIA (Reuters) - Brazil's federal government wants to halt COVID-19 vaccinations for most adolescents, citing a death under investigation and adverse events after some 3.5

Almost 90% of people in India's financial capital have COVID-19 antibodies: survey

By Reuters Staff MUMBAI (Reuters) - Nearly 90% of people in India's financial capital, Mumbai, are estimated to have COVID-19 antibodies, according to the civic body survey released on Friday. The

Work-related deaths kill nearly 2 mln people a year: UN agencies

By Reuters Staff GENEVA (Reuters) - Nearly 2 million people die from work-related causes each year, including from illnesses associated with long working hours and air pollution, an estimate from U.N.

U.S. COVID-19 booster debate moves to FDA vaccine advisory committee

By Manojna Maddipatla (Reuters) - The debate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine moves to a panel of independent expert advisers to the U.S.

British study to test mixed COVID-19 vaccine dose schedules in children

By Alistair Smout LONDON (Reuters) - A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach

Telemedicine visits for medically complex kids reduce serious illness, health costs

By Lisa Rapaport (Reuters Health) - Providing telemedicine in addition to comprehensive care for medically complex children can reduce care days outside the home, serious illness, and health care

Blacks with hypertension also seem to benefit from amlodipine with benazepril

By Marilynn Larkin NEW YORK (Reuters Health) - In hypertensive patients, including Blacks, combining amlodipine, rather than hydrochlorothiazide, with benazepril effectively reduced multiple

Basic mitigation strategies can cut COVID-19 transmission in schools

By Marilynn Larkin NEW YORK (Reuters Health) - Within-school COVID-19 transmission in North Carolina was significantly limited by the use of basic mitigation strategies such as universal masking,

Congenital syphilis still diagnosed beyond neonatal period in U.S.

By Lisa Rapaport (Reuters Health) - The annual number of congenital syphilis cases reported to the U.S. Centers for Disease Control and Prevention (CDC) surged 183% from 462 cases in 2014 to 1,306

Online CBT-based workshop reduces postpartum depression and anxiety

By Linda Carroll (Reuters Health) - A one-day, online cognitive behavioral therapy-based workshop along with usual care can improve postpartum depression and anxiety, a new study suggests. In a trial

Guinea declares end of Marburg virus outbreak

By Reuters Staff CONAKRY (Reuters) - An outbreak of the deadly Marburg virus in Guinea is officially over, health authorities said on Thursday, less than six weeks since West Africa's first ever case

Italy readies law to make COVID health pass mandatory for all workers

By Crispian Balmer and Giuseppe Fonte ROME (Reuters) - Italy is poised to introduce some of the strictest anti-COVID measures in the world on Thursday, making it obligatory for all workers either to

EU launches health crisis body to prepare for future pandemic

By Reuters Staff BRUSSELS (Reuters) - The European Commission launched on Thursday a health crisis body that will coordinate EU spending of almost 30 billion euros ($35.3 billion) to prepare for a

Pfizer recalls all lots of anti-smoking drug over carcinogen presence

By Reuters Staff (Reuters) - Pfizer Inc said on Thursday it was recalling all lots of its anti-smoking treatment, Chantix, due to high levels of cancer-causing agents called nitrosamines in the pills.

CORRECTED-Moderna says COVID-19 vaccine protection wanes, makes case for booster

(In 8th paragraph, changes year to 2021 from 2022) By Julie Steenhuysen CHICAGO (Reuters) - New data from Moderna Inc's large COVID-19 vaccine trial shows that the protection it offers declines over

U.S. FDA approves Takeda's lung cancer therapy

By Reuters Staff (Reuters) - Japanese pharma company Takeda Pharmaceutical Co said on Wednesday the U.S. Food and Drug Administration approved its drug, Exkivity, to treat a type of lung cancer.

Adding ADT to radiation works better than upping radiation dose for some prostate cancers

By Lorraine L. Janeczko NEW YORK (Reuters Health) - In localized prostate cancer, adding androgen-deprivation therapy (ADT) to radiation therapy (RT) may work better than increasing the radiation dose

Hydroxyurea may reverse sickle cell-related cardiac abnormalities over time

By Reuters Staff NEW YORK (Reuters Health) - A new study confirms that cardiac abnormalities are common in children and young adults with sickle cell anemia (SCA) and suggests timely initiation of

New guidelines provide framework for safe liver transplantation for non-resectable colorectal liver metastases

By Reuters Staff NEW YORK (Reuters Health) - Growing interest in liver transplantation to treat non-resectable colorectal liver metastases prompted an international working group to develop consensus

Pretreatment levels of ctDNA may predict survival in some lung-cancer patients

By Megan Brooks NEW YORK (Reuters Health) - Pretreatment circulating tumor (ct)DNA levels may help identify which stage-IIIA non-small-cell lung cancer (NSCLC) patients are likely to benefit from

Asia supercharges vaccination efforts after slow start, U.S. lags

By Rocky Swift and Aradhana Aravindan TOKYO/SINGAPORE (Reuters) - Several Asian nations are quickly ramping up vaccination campaigns from shaky starts to combat growing COVID-19 infections, as supply

French hospital worker: I'm on hunger strike over vaccine mandate

By Eric Gaillard NICE, France (Reuters) - A French hospital worker has said he is on hunger strike to protest against a government rule that healthcare workers will be suspended if they are not

France suspends 3,000 health staff as Europe targets vaccine refusal

By Matthieu Protard and Ingrid Melander PARIS (Reuters) - Hospitals, care homes and health centres have suspended around 3,000 workers across France for failing to comply with mandatory COVID

UPDATE 3-FDA staff say Pfizer COVID-19 boosters improve immunity but may not be needed

(Adds details from FDA document, upcoming CDC meeting) By Michael Erman (Reuters) - U.S. Food and Drug Administration scientists said on Wednesday that booster doses of Pfizer's COVID-19 vaccine may

Congenital syphilis cases in the U.S. highest in 25 years

By Gene Emery NEW YORK (Reuters Health) - Syphilis in children is on the rise again in the United States. A new analysis by the Centers for Disease Control and Prevention (CDC) has found that the

Single-dose typhoid vaccine 84% effective in Africa trial

By Gene Emery NEW YORK (Reuters Health) - A single dose of the Vi-TCV typhoid fever vaccine was more than 80% effective in a test of 28,130 Malawian children aged nine months to 12 years, according to

Moderna says COVID-19 vaccine protection wanes, makes case for booster

By Julie Steenhuysen CHICAGO (Reuters) - New data from Moderna Inc's large COVID-19 vaccine trial shows that the protection it offers declines over time, supporting the case for booster doses, the

New method detects hard to diagnose CNS neoplasms

By Linda Carroll (Reuters Health) - DNA sequencing of cerebrospinal fluid samples can help detect difficult to diagnose central nervous system (CNS) neoplasms that may mimic infections and autoimmune

Unvaccinated children suffering COVID impact, Americas health agency warns

By Anthony Boadle BRASILIA (Reuters) - As more adults get their COVID-19 vaccines, children who are not yet eligible for vaccination in most countries are representing a larger percentage of

As Zika-affected babies grow, developmental outcomes vary

By Reuters Staff NEW YORK (Reuters Health) - At age 2 years and beyond, babies born with microcephaly after exposure to Zika virus in the womb often have more severe neurodevelopmental delays and

UPDATE 2-FDA staff say Pfizer COVID-19 boosters improve immunity but may not be needed

(Adds details from FDA staff documents) By Michael Erman (Reuters) - U.S. Food and Drug Administration scientists said on Wednesday that a third booster dose of Pfizer's COVID-19 vaccine generates a

ANALYSIS-Hospital strain to test UK's vaccine-based winter COVID plan

By Alistair Smout LONDON (Reuters) - British Prime Minister Boris Johnson is hoping to get through winter without any more coronavirus lockdowns, but doctors and scientists warn that relying largely

White House plans 'new system' for international travel

By David Shepardson WASHINGTON (Reuters) - White House coronavirus response coordinator Jeff Zients said on Wednesday the United States is developing a "new system for international travel" that will

COVID cases surge in North America, decline in South America, says health agency

By Reuters Staff BRASILIA (Reuters) - COVID-19 infections have risen by a third in North America over the past week, due to surges in the United States and Canada, where new infections have doubled in

Late mortality decreasing among some allogeneic BMT recipients

By Marilynn Larkin NEW YORK (Reuters Health) - While late mortality among allogenic bone marrow transplant (BMT) patients has decreased over the past 40 years, the declines seemed to be confined to

HIV tied to higher risk of sudden cardiac death

By Marilynn Larkin NEW YORK (Reuters Health) - HIV infection was associated with a greater risk of sudden cardiac death (SCD) in an observational study, especially among those with poor HIV disease

UPDATE 1-Pfizer says third COVID-19 shot warranted in FDA document

(Adds background, FDA comment) By Michael Erman (Reuters) - Pfizer Inc said that U.S. regulators should approve a third booster dose of the COVID-19 vaccine it developed with Germany's BioNTech SA six

AbCellera and Moderna team up to develop antibody therapies

By Reuters Staff (Reuters) - Peter Thiel-backed AbCellera Biologics Inc said on Wednesday it had entered a multi-year agreement with COVID-19 vaccine maker Moderna Inc to develop antibody therapies

Cuba seeks WHO approval of COVID-19 vaccines as toddlers next for shot

By Marc Frank HAVANA (Reuters) - Cuba on Thursday will seek World Health Organization (WHO) approval of three COVID-19 vaccines, according to the state-run corporation that produces them, as it begins

Nearly 3 mln Americans sign up for healthcare during special enrollment period

By Nandita Bose WASHINGTON (Reuters) - Nearly three million Americans have signed up for health insurance on the U.S. government website Healthcare.gov during a special enrollment period that began on

Severe COVID-19 tied to new-onset IgG autoantibodies

By Reuters Staff NEW YORK (Reuters Health) - New research confirms emerging reports of IgG autoantibodies in patients with severe COVID-19 and demonstrates that many of these patients will develop

'Concerning' low rates of durvalumab maintenance therapy in NSCLC in US

By Megan Brooks NEW YORK (Reuters Health) - Many patients with unresectable stage-III non-small-cell lung cancer (NSCLC) in the United States are not receiving standard-of-care durvalumab maintenance

Pfizer says third COVID-19 shot warranted in FDA document

By Reuters Staff (Reuters) - Pfizer Inc said that U.S. regulators should approve a third booster dose of the COVID-19 vaccine it developed with Germany's BioNTech SA six months after the second dose

At French care home, some staff quit over vaccine mandate

By Caroline Pailliez and Clotaire Achi BORDEAUX, France (Reuters) - Emmanuel Chignon managed to keep his care home in western France running through the worst of the COVID-19 pandemic, but now he is

'It's not ethical': a French hospital worker's anger at suspension over vaccine

By Antony Paone PARIS (Reuters) - Vanessa Perotti's day at work was brief on Wednesday, lasting long enough for the medical secretary to be handed notice of her indefinite suspension because she

Australian university says Chinese Uyghur study breached ethics code

By Kirsty Needham SYDNEY (Reuters) - An Australian university said on Wednesday that it has asked journal publisher Wiley Online Library to retract a research study conducted by a former faculty

ANALYSIS-U.S. hopes COVID vaccine boosters will decrease not just deaths, but virus spread

By Julie Steenhuysen CHICAGO (Reuters) - U.S. officials preparing to roll out COVID-19 booster shots in the face of waning vaccine protection and surging hospitalizations and deaths caused by the

Higher mortality among patients of hospitalists who work fewest days

By Linda Carroll (Reuters Health) - For older patients admitted with an emergency condition, 30-day mortality is greater when they're treated by hospitalists who spend the least time working

Screen time tied to slower concussion recovery time in youth

By Lisa Rapaport (Reuters Health) - Youth who sustain concussions may have a faster recovery when they abstain from screen time during the first 48 hours after injury, a randomized clinical trial

U.S. pushes world leaders to embrace 70% global COVID-19 vaccination target

By Reuters Staff WASHINGTON (Reuters) - The United States is pushing global leaders to endorse what it calls ambitious targets for ending the COVID-19 pandemic, including ensuring 70% of the world's

Tourette syndrome tied to cervical spine disorders

By Lisa Rapaport (Reuters Health) - People with Tourette syndrome or chronic tic disorder are more likely to develop cervical spine disorders than the general population, a Swedish study suggests.

U.S. judge blocks N.Y. vaccine mandate for healthcare workers

By Daniel Wiessner (Reuters) - A U.S. judge in New York on Tuesday temporarily blocked the state from enforcing a requirement that healthcare workers receive COVID-19 vaccines against the wishes of

African Union slams vaccine manufacturers for restricting access

By Reuters Staff GENEVA (Reuters) - The African Union on Tuesday accused manufacturers of COVID-19 vaccines of denying African countries a fair chance to buy them, and urged manufacturing countries -

U.S. government aid helped reduce poverty in 2020, Census data shows

By Jonnelle Marte (Reuters) - Direct cash payments to households and generous unemployment benefits helped to keep millions of Americans out of poverty after the coronavirus pandemic severely

Radiation exposure during cardiac cath on the decline

By Brandon May NEW YORK (Reuters Health) - Radiation exposure associated with diagnostic cardiac catheterization (DCC) has dropped over the past decade, possibly due to technological advances and

Upfront camrelizumab plus chemo yields survival benefit in advanced esophageal SCC

By Reuters Staff NEW YORK (Reuters Health) - Adding camrelizumab to chemotherapy improves overall survival and progression-free survival when used as first-line therapy for advanced or metastatic

USPSTF reaffirms advice on chlamydia and gonorrhea screening

By Megan Brooks NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend screening for chlamydia and gonorrhea in sexually active women aged 24 and younger

UK would not have approved Valneva COVID vaccine, health secretary says

By Reuters Staff LONDON (Reuters) - Britain cancelled its contract for about 100 million doses of a COVID-19 vaccine being developed by France's Valneva in part because it was clear it would not be

CureVac slashes COVID-19 vaccine production plans

By Reuters Staff FRANKFURT (Reuters) - German biotech firm CureVac said on Tuesday it cancelled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners, after

Rheumatologists more likely than nephrologists to use rituximab in kids with lupus nephritis

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Pediatric rheumatologists and nephrologists appear to differ in their treatment choices for children who have lupus nephritis (LN), with

Heightened prostate cancer risk after less than 6 years seen among 9/11 responders

By Linda Carroll (Reuters Health) - Rescue and recovery workers who were at the World Trade Center site on or after September 11, 2001 started showing an increased risk for prostate cancer more than

Triple therapy boosts survival in metastatic non-small-cell lung cancer

By Megan Brooks NEW YORK (Reuters Health) - The combination of two immune-checkpoint inhibitors (durvalumab and tremelimumab) plus platinum-based chemotherapy significantly improves progression-free

Florida governor threatens fines for cities, counties over vaccine mandates

By Reuters Staff (Reuters) - Florida Governor Ron DeSantis has threatened fines for cities and counties that mandate employees must get vaccinated against COVID-19, which has killed nearly 50,000

UK plans COVID boosters for over 50s to cope with 'bumpy' winter

By Alistair Smout LONDON (Reuters) - Britain will begin a broad-based COVID-19 vaccine booster programme for those older and more vulnerable adults soon as Prime Minister Boris Johnson's government

EXCLUSIVE-WHO-backed vaccine hub for Africa to copy Moderna COVID-19 shot

By Wendell Roelf CAPE TOWN (Reuters) - Efforts to develop an African base for COVID-19 vaccine production will focus on trying to replicate Moderna's shot, but a lack of progress in talks with the U.S

UK likely to require health workers to be vaccinated against COVID

By Reuters Staff LONDON (Reuters) - Britain is highly likely to require front-line health and social care workers in England to be vaccinated against COVID-19 as part of its plan to contain the virus

FACTBOX-Countries weigh need for booster COVID-19 shots

(Updates to add details from countries including Britain, Argentina, Italy, Ireland, Serbia, Spain.) By Reuters Staff Sept 14 (Reuters) - COVID-19 vaccine booster shots will be made widely available

Indian study finds big drop in COVID antibodies within four months of vaccination

By Jatindra Dash and Krishna N. Das BHUBANESWAR, India (Reuters) - A study https://www.researchsquare.com/article/rs-888762/v1 of 614 fully vaccinated health workers in India found a "significant"

Cognitively stimulating jobs tied to lower dementia risk

By Lisa Rapaport (Reuters Health) - Individuals who get higher levels of cognitive stimulation at work may have a lower risk of dementia as they age than peers with less stimulating jobs, a new study

'Considerable' bleeding risk with extended anticoagulant therapy after first unexplained VTE

By Megan Brooks NEW YORK (Reuters Health) - After a first unprovoked venous thromboembolism (VTE), extended use of anticoagulant therapy (beyond the initial three to six months) is associated with "

Heart failure patients who forgo, delay care face higher costs

By Lisa Rapaport (Reuters Health) - Heart failure patients who postpone or forgo care have higher average total annual healthcare expenditures than those who don't miss medical treatments, a U.S.

UPDATE 1-England to offer COVID vaccine to all 12- to 15-year-olds

(Recasts with government decision) By Alistair Smout LONDON (Reuters) - All 12- to 15-year-olds in England will be offered a COVID-19 vaccine after top medical advisers said on Monday that children

PCSK9 inhibitors may not be sufficient to curb atherosclerotic cardiovascular disease

By Marilynn Larkin NEW YORK (Reuters Health) - PCSK9 inhibitors may only partly address the portion of atherosclerotic cardiovascular disease risk mediated through the lipoprotein a Lp(a)/oxidized

Israeli survey finds about 1 in 10 kids have lingering COVID symptoms

By Reuters Staff JERUSALEM (Reuters) - About one in 10 children had symptoms that remained after recovering from COVID-19, though that number dropped by more than half as the months passed, a Health

Genetically engineered cells deliver RA drug in mouse study

By Marilynn Larkin NEW YORK (Reuters Health) - Researchers have created cells that automatically secrete an anti-cytokine drug in response to inflammation when implanted in a mouse model of rheumatoid

Abortion providers urge U.S. Supreme Court to uphold Roe v. Wade landmark

By Lawrence Hurley WASHINGTON (Reuters) - Abortion rights advocates on Monday urged the U.S. Supreme Court not to overturn the Roe v. Wade ruling that legalized abortion nationwide - a 1973 landmark

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information